Cargando…

Circulating Tumor Cell Composition in Renal Cell Carcinoma

PURPOSE: Due to their minimal-invasive yet potentially current character circulating tumor cells (CTC) might be useful as a “liquid biopsy” in solid tumors. However, successful application in metastatic renal cell carcinoma (mRCC) has been very limited so far. High plasticity and heterogeneity of CT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nel, Ivonne, Gauler, Thomas C., Bublitz, Kira, Lazaridis, Lazaros, Goergens, André, Giebel, Bernd, Schuler, Martin, Hoffmann, Andreas-Claudius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839694/ https://www.ncbi.nlm.nih.gov/pubmed/27101285 http://dx.doi.org/10.1371/journal.pone.0153018

Ejemplares similares

Detection of Circulating Tumor Cell Subpopulations in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Weller, Patrick, et al.
Publicado: (2014)

Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment
por: Nel, I, et al.
Publicado: (2013)

The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients
por: Nel, Ivonne, et al.
Publicado: (2021)

Systemic therapy in metastatic renal cell carcinoma
por: Bedke, Jens, et al.
Publicado: (2016)

Circulating Tumor Cells for the Management of Renal Cell Carcinoma
por: Broncy, Lucile, et al.
Publicado: (2018)

Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients
por: Breitenbuecher, Frank, et al.
Publicado: (2014)

Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N)
por: Ivanyi, Philipp, et al.
Publicado: (2020)

Comparison of isolation platforms for detection of circulating renal cell carcinoma cells
por: Maertens, Yvonne, et al.
Publicado: (2017)

An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma
por: Grünwald, Viktor, et al.
Publicado: (2018)

Circulating tumor DNA analysis of metastatic renal cell carcinoma
por: Zhang, Jingbo, et al.
Publicado: (2021)

Circulating Tumor Cells in Gastrointestinal Malignancies: Current Techniques and Clinical Implications
por: Lurje, Georg, et al.
Publicado: (2010)

Dendritic cell generation and CD4(+)CD25(HIGH)FOXP3(+ )regulatory T cells in human head and neck carcinoma during Radio-chemotherapy
por: Schuler, PJ, et al.
Publicado: (2011)

Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges
por: Santoni, Matteo, et al.
Publicado: (2019)

Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma
por: Song, Jinbo, et al.
Publicado: (2021)

Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?
por: Couto-Cunha, Anabela, et al.
Publicado: (2022)

Clinical values of circulating tumor cells count in localized renal cell carcinoma
por: Wang, Qirui, et al.
Publicado: (2023)

Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2020)

Unveiling the World of Circulating and Exosomal microRNAs in Renal Cell Carcinoma
por: Sequeira, José Pedro, et al.
Publicado: (2021)

Tumor thrombus of inferior vena cava in patients with renal cell carcinoma – clinical and oncological outcome of 50 patients after surgery
por: Vergho, Daniel Claudius, et al.
Publicado: (2012)

Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib
por: Gruenwald, Viktor, et al.
Publicado: (2010)

Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine
por: Francini, Edoardo, et al.
Publicado: (2022)

Prevention of Herpes Simplex Virus Induced Stromal Keratitis by a Glycoprotein B-Specific Monoclonal Antibody
por: Krawczyk, Adalbert, et al.
Publicado: (2015)

Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group
por: Grünwald, V., et al.
Publicado: (2022)

Impaired Retinal Circulation during Axitinib Treatment for Metastatic Renal Cell Carcinoma
por: Kimura, Masashi, et al.
Publicado: (2019)

Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites
por: Bezwada, Divya, et al.
Publicado: (2023)

Circulating Th22 cells, as well as Th17 cells, are elevated in patients with renal cell carcinoma
por: Peng, Zhiguo, et al.
Publicado: (2021)

The Surge in the Number of Circulating Tumor Cells Following Treatment with Sunitinib for Metastatic Renal Cell Carcinoma
por: Nagaya, Naoya, et al.
Publicado: (2018)

Detection of Circulating Tumor Cells in Renal Cell Carcinoma: Disease Stage Correlation and Molecular Characterization
por: Klezl, Petr, et al.
Publicado: (2020)

Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis
por: Li, Yong, et al.
Publicado: (2021)

Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma
por: He, Xing, et al.
Publicado: (2022)

Sex Differences in Renal Cell Carcinoma: The Importance of Body Composition
por: Dahlmann, Sebastian, et al.
Publicado: (2022)

Transdiaphragmatic nephrectomy with synchronous pulmonary and anterior thoracic wall mass metastasectomy in a young male with metastatic renal cell carcinoma; a single-incision approach
por: Lazarou, Lazaros, et al.
Publicado: (2021)

Identification of a Prognostic Clinical Score for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With Systemic Therapy Including Cetuximab
por: Pogorzelski, Michael, et al.
Publicado: (2021)

Circulating Biomarkers of One-Carbon Metabolism in Relation to Renal Cell Carcinoma Incidence and Survival
por: Johansson, Mattias, et al.
Publicado: (2014)

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2019)

Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts
por: Iafolla, Marco A J, et al.
Publicado: (2020)

Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts
por: Iafolla, Marco A. J., et al.
Publicado: (2019)

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2021)

Circulating Tumor DNA in Patients with Renal Cell Carcinoma. A Systematic Review of the Literature
por: Geertsen, Louise, et al.
Publicado: (2022)

Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?
por: El-Heliebi, Amin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_446h4tt750o8q9t8q2nvthovjf